By Sarina Isaacs
Shares of OraSure were higher after the maker of infectious-disease diagnostic tests said it would repurchase up to $40 million of its shares.
The stock was recently up 13% at $3.87. Shares are still down nearly 40% over the past year.
The Bethlehem, Pa., company on Monday said its board has authorized the repurchase of up to $40 million of its common stock over the next two years. The buyback is to be funded by cash on hand, OraSure said.
Write to Sarina Isaacs at sarina.isaacs@wsj.com
(END) Dow Jones Newswires
March 24, 2025 10:44 ET (14:44 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.